![Alexandra Dietrich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexandra Dietrich
Algemeen Directeur bij Syntacoll Gmbh
Oorsprong van het eerstegraads netwerk van Alexandra Dietrich
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Syntacoll Gmbh
![]() Syntacoll Gmbh Pharmaceuticals: MajorHealth Technology Part of Innocoll Holdings Plc, Syntacoll GmbH is a German pharmaceutical company that develops and manufactures fully resorbable collagen-based implants. The company is based in Saal an der Donau, Germany and was founded in 1992. The CEOs are Alexandra Dietrich and Kimball Hall. Syntacoll is the only development and production site of Innocoll, and their products are manufactured according to GMP and ISO 13485 standards. The company holds a manufacturing license for active substance-containing drugs based on collagen. Syntacoll's mission is to provide innovative medical and pharmaceutical products for patient care, and their vision is to be recognized as one of the leading providers of medical and pharmaceutical products worldwide. The company values integrity, inclusion, collaboration, and responsibility.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Alexandra Dietrich via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ABZENA PLC | Biotechnology | President | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree | |
VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Abzena Holdings Us LLC | President | ||
INNOCOLL HOLDINGS PLC | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 6 |
Verenigd Koninkrijk | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Operationeel
President | 3 |
Director/Board Member | 2 |
Chief Operating Officer | 2 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Sterkste connecties
Insiders | |
---|---|
Kimball Hall | 7 |
- Beurs
- Insiders
- Alexandra Dietrich
- Bedrijfsconnecties